nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—skin cancer—peripheral nervous system neoplasm	0.525	1	CtDrD
Vismodegib—ABCB1—peripheral nervous system neoplasm	0.14	1	CbGaD
Vismodegib—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0366	0.153	CbGbCtD
Vismodegib—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0254	0.106	CbGbCtD
Vismodegib—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0181	0.0758	CbGbCtD
Vismodegib—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0156	0.0654	CbGbCtD
Vismodegib—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0146	0.061	CbGbCtD
Vismodegib—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0143	0.0599	CbGbCtD
Vismodegib—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0132	0.0552	CbGbCtD
Vismodegib—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0132	0.0552	CbGbCtD
Vismodegib—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0126	0.0529	CbGbCtD
Vismodegib—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.00976	0.0409	CbGbCtD
Vismodegib—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00914	0.0383	CbGbCtD
Vismodegib—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0079	0.0331	CbGbCtD
Vismodegib—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.00762	0.0319	CbGbCtD
Vismodegib—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00735	0.0308	CbGbCtD
Vismodegib—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00563	0.0236	CbGbCtD
Vismodegib—SHH—skull—peripheral nervous system neoplasm	0.00555	0.348	CbGeAlD
Vismodegib—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00541	0.0227	CbGbCtD
Vismodegib—SHH—forelimb—peripheral nervous system neoplasm	0.00534	0.335	CbGeAlD
Vismodegib—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00525	0.022	CbGbCtD
Vismodegib—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00516	0.0216	CbGbCtD
Vismodegib—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00352	0.0147	CbGbCtD
Vismodegib—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00337	0.0141	CbGbCtD
Vismodegib—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00309	0.0129	CbGbCtD
Vismodegib—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00211	0.00883	CbGbCtD
Vismodegib—SHH—brainstem—peripheral nervous system neoplasm	0.00125	0.0788	CbGeAlD
Vismodegib—SMO—trigeminal ganglion—peripheral nervous system neoplasm	0.000991	0.0623	CbGeAlD
Vismodegib—SMO—parotid gland—peripheral nervous system neoplasm	0.000935	0.0587	CbGeAlD
Vismodegib—SHH—cerebellum—peripheral nervous system neoplasm	0.000618	0.0388	CbGeAlD
Vismodegib—Tolvaptan—ABCB1—peripheral nervous system neoplasm	0.000464	0.704	CrCbGaD
Vismodegib—SMO—cerebellum—peripheral nervous system neoplasm	0.000433	0.0272	CbGeAlD
Vismodegib—SMO—Class B/2 (Secretin family receptors)—GNAS—peripheral nervous system neoplasm	0.000343	0.0134	CbGpPWpGaD
Vismodegib—SMO—Hedgehog 'off' state—GNAS—peripheral nervous system neoplasm	0.000312	0.0122	CbGpPWpGaD
Vismodegib—SHH—Validated transcriptional targets of TAp63 isoforms—CDKN2A—peripheral nervous system neoplasm	0.000305	0.0119	CbGpPWpGaD
Vismodegib—SHH—Signaling by Hedgehog—GNAS—peripheral nervous system neoplasm	0.000294	0.0115	CbGpPWpGaD
Vismodegib—SHH—Signaling events mediated by the Hedgehog family—AKT1—peripheral nervous system neoplasm	0.000283	0.0111	CbGpPWpGaD
Vismodegib—SMO—Signaling by Hedgehog—GNAS—peripheral nervous system neoplasm	0.000279	0.0109	CbGpPWpGaD
Vismodegib—SMO—Signaling events mediated by the Hedgehog family—AKT1—peripheral nervous system neoplasm	0.000269	0.0105	CbGpPWpGaD
Vismodegib—ABCG2—trigeminal ganglion—peripheral nervous system neoplasm	0.00026	0.0163	CbGeAlD
Vismodegib—SHH—Hair Follicle Development: Induction (Part 1 of 3)—MYC—peripheral nervous system neoplasm	0.000252	0.00986	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000252	0.00985	CbGpPWpGaD
Vismodegib—ABCG2—parotid gland—peripheral nervous system neoplasm	0.000245	0.0154	CbGeAlD
Vismodegib—SHH—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000242	0.00944	CbGpPWpGaD
Vismodegib—SMO—Hair Follicle Development: Induction (Part 1 of 3)—MYC—peripheral nervous system neoplasm	0.000239	0.00935	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000239	0.00934	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000231	0.00902	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000229	0.00895	CbGpPWpGaD
Vismodegib—ABCG2—HIF-2-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000227	0.00888	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000219	0.00855	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.00021	0.00822	CbGpPWpGaD
Vismodegib—Arthralgia—Isotretinoin—peripheral nervous system neoplasm	0.0002	0.0037	CcSEcCtD
Vismodegib—Arthralgia—Tretinoin—peripheral nervous system neoplasm	0.0002	0.0037	CcSEcCtD
Vismodegib—Myalgia—Isotretinoin—peripheral nervous system neoplasm	0.0002	0.0037	CcSEcCtD
Vismodegib—Myalgia—Tretinoin—peripheral nervous system neoplasm	0.0002	0.0037	CcSEcCtD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000199	0.00779	CbGpPWpGaD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.000199	0.00368	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.000199	0.00368	CcSEcCtD
Vismodegib—Myalgia—Melphalan—peripheral nervous system neoplasm	0.000197	0.00365	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.000196	0.00363	CcSEcCtD
Vismodegib—Sorafenib—ABCB1—peripheral nervous system neoplasm	0.000196	0.297	CrCbGaD
Vismodegib—Alopecia—Dactinomycin—peripheral nervous system neoplasm	0.000195	0.00361	CcSEcCtD
Vismodegib—Connective tissue disorder—Vincristine—peripheral nervous system neoplasm	0.000194	0.00358	CcSEcCtD
Vismodegib—Neoplasm malignant—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.00357	CcSEcCtD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000193	0.00753	CbGpPWpGaD
Vismodegib—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00019	0.00743	CbGpPWpGaD
Vismodegib—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.00019	0.00351	CcSEcCtD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000189	0.0074	CbGpPWpGaD
Vismodegib—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.000188	0.00348	CcSEcCtD
Vismodegib—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.000188	0.00348	CcSEcCtD
Vismodegib—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.000188	0.00347	CcSEcCtD
Vismodegib—Amenorrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.00347	CcSEcCtD
Vismodegib—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000186	0.00345	CcSEcCtD
Vismodegib—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000186	0.00345	CcSEcCtD
Vismodegib—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.000184	0.0034	CcSEcCtD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000183	0.00714	CbGpPWpGaD
Vismodegib—Alopecia—Alitretinoin—peripheral nervous system neoplasm	0.000181	0.00334	CcSEcCtD
Vismodegib—Musculoskeletal pain—Epirubicin—peripheral nervous system neoplasm	0.00018	0.00334	CcSEcCtD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.00018	0.00702	CbGpPWpGaD
Vismodegib—Phosphatase alkaline increased—Epirubicin—peripheral nervous system neoplasm	0.000178	0.0033	CcSEcCtD
Vismodegib—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.000178	0.00329	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.000176	0.00326	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.000175	0.00323	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000175	0.00323	CcSEcCtD
Vismodegib—Alopecia—Vincristine—peripheral nervous system neoplasm	0.000174	0.00322	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.000172	0.00319	CcSEcCtD
Vismodegib—Back pain—Alitretinoin—peripheral nervous system neoplasm	0.000172	0.00319	CcSEcCtD
Vismodegib—Connective tissue disorder—Cisplatin—peripheral nervous system neoplasm	0.000171	0.00317	CcSEcCtD
Vismodegib—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.00017	0.00315	CcSEcCtD
Vismodegib—ALB—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	0.00017	0.00663	CbGpPWpGaD
Vismodegib—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000169	0.00312	CcSEcCtD
Vismodegib—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000169	0.00312	CcSEcCtD
Vismodegib—Blood urea increased—Epirubicin—peripheral nervous system neoplasm	0.000168	0.00311	CcSEcCtD
Vismodegib—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000168	0.00311	CcSEcCtD
Vismodegib—Musculoskeletal pain—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.00309	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000167	0.00309	CcSEcCtD
Vismodegib—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000167	0.00308	CcSEcCtD
Vismodegib—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000167	0.00308	CcSEcCtD
Vismodegib—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000167	0.00308	CcSEcCtD
Vismodegib—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000167	0.00308	CcSEcCtD
Vismodegib—Back pain—Vincristine—peripheral nervous system neoplasm	0.000166	0.00307	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000166	0.00306	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000166	0.00306	CcSEcCtD
Vismodegib—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000165	0.00306	CcSEcCtD
Vismodegib—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000165	0.00306	CcSEcCtD
Vismodegib—Pain—Topotecan—peripheral nervous system neoplasm	0.000165	0.00306	CcSEcCtD
Vismodegib—Constipation—Topotecan—peripheral nervous system neoplasm	0.000165	0.00306	CcSEcCtD
Vismodegib—Phosphatase alkaline increased—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.00305	CcSEcCtD
Vismodegib—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000165	0.00304	CcSEcCtD
Vismodegib—Pain—Tretinoin—peripheral nervous system neoplasm	0.000164	0.00303	CcSEcCtD
Vismodegib—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000164	0.00303	CcSEcCtD
Vismodegib—Pain—Isotretinoin—peripheral nervous system neoplasm	0.000164	0.00303	CcSEcCtD
Vismodegib—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000164	0.00303	CcSEcCtD
Vismodegib—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.000163	0.00303	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000163	0.00302	CcSEcCtD
Vismodegib—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000163	0.00302	CcSEcCtD
Vismodegib—Pain—Melphalan—peripheral nervous system neoplasm	0.000162	0.00299	CcSEcCtD
Vismodegib—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000161	0.0063	CbGpPWpGaD
Vismodegib—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000158	0.00292	CcSEcCtD
Vismodegib—SHH—Hedgehog signaling events mediated by Gli proteins—AKT1—peripheral nervous system neoplasm	0.000157	0.00615	CbGpPWpGaD
Vismodegib—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000157	0.0029	CcSEcCtD
Vismodegib—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000157	0.0029	CcSEcCtD
Vismodegib—Blood urea increased—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.00288	CcSEcCtD
Vismodegib—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.000154	0.00285	CcSEcCtD
Vismodegib—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000153	0.00283	CcSEcCtD
Vismodegib—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.000152	0.00281	CcSEcCtD
Vismodegib—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000152	0.00281	CcSEcCtD
Vismodegib—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000152	0.00281	CcSEcCtD
Vismodegib—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000152	0.0028	CcSEcCtD
Vismodegib—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000152	0.0028	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000151	0.00279	CcSEcCtD
Vismodegib—SMO—Hedgehog signaling events mediated by Gli proteins—AKT1—peripheral nervous system neoplasm	0.000149	0.00583	CbGpPWpGaD
Vismodegib—Blood alkaline phosphatase increased—Epirubicin—peripheral nervous system neoplasm	0.000149	0.00275	CcSEcCtD
Vismodegib—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000146	0.0027	CcSEcCtD
Vismodegib—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000146	0.0027	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000143	0.00264	CcSEcCtD
Vismodegib—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000143	0.00264	CcSEcCtD
Vismodegib—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000141	0.00261	CcSEcCtD
Vismodegib—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000141	0.00261	CcSEcCtD
Vismodegib—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000139	0.00257	CcSEcCtD
Vismodegib—Blood alkaline phosphatase increased—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.00255	CcSEcCtD
Vismodegib—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000138	0.00255	CcSEcCtD
Vismodegib—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000138	0.00255	CcSEcCtD
Vismodegib—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000137	0.00254	CcSEcCtD
Vismodegib—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000137	0.00253	CcSEcCtD
Vismodegib—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000136	0.00252	CcSEcCtD
Vismodegib—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000136	0.00252	CcSEcCtD
Vismodegib—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000136	0.00251	CcSEcCtD
Vismodegib—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000136	0.00251	CcSEcCtD
Vismodegib—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000136	0.00251	CcSEcCtD
Vismodegib—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000135	0.0025	CcSEcCtD
Vismodegib—Back pain—Etoposide—peripheral nervous system neoplasm	0.000134	0.00249	CcSEcCtD
Vismodegib—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000134	0.00248	CcSEcCtD
Vismodegib—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000134	0.00248	CcSEcCtD
Vismodegib—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—peripheral nervous system neoplasm	0.000134	0.00523	CbGpPWpGaD
Vismodegib—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000134	0.00247	CcSEcCtD
Vismodegib—ABCG2—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000134	0.00522	CbGpPWpGaD
Vismodegib—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000132	0.00245	CcSEcCtD
Vismodegib—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000132	0.00245	CcSEcCtD
Vismodegib—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000131	0.00243	CcSEcCtD
Vismodegib—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000131	0.00243	CcSEcCtD
Vismodegib—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.00013	0.0024	CcSEcCtD
Vismodegib—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00013	0.0024	CcSEcCtD
Vismodegib—Pain in extremity—Epirubicin—peripheral nervous system neoplasm	0.000129	0.00239	CcSEcCtD
Vismodegib—SHH—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000129	0.00505	CbGpPWpGaD
Vismodegib—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000129	0.00239	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000128	0.00237	CcSEcCtD
Vismodegib—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000128	0.00237	CcSEcCtD
Vismodegib—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000128	0.00804	CbGeAlD
Vismodegib—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000128	0.00237	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000128	0.00236	CcSEcCtD
Vismodegib—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000126	0.00234	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000125	0.00232	CcSEcCtD
Vismodegib—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000125	0.00232	CcSEcCtD
Vismodegib—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000124	0.0023	CcSEcCtD
Vismodegib—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000124	0.0023	CcSEcCtD
Vismodegib—SHH—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000124	0.00484	CbGpPWpGaD
Vismodegib—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000124	0.00229	CcSEcCtD
Vismodegib—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000123	0.00227	CcSEcCtD
Vismodegib—SMO—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000123	0.00479	CbGpPWpGaD
Vismodegib—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000122	0.00226	CcSEcCtD
Vismodegib—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000122	0.00226	CcSEcCtD
Vismodegib—Rash—Topotecan—peripheral nervous system neoplasm	0.000122	0.00226	CcSEcCtD
Vismodegib—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000122	0.00225	CcSEcCtD
Vismodegib—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000122	0.00225	CcSEcCtD
Vismodegib—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000121	0.00225	CcSEcCtD
Vismodegib—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000121	0.00224	CcSEcCtD
Vismodegib—Rash—Tretinoin—peripheral nervous system neoplasm	0.000121	0.00224	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000121	0.00224	CcSEcCtD
Vismodegib—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000121	0.00224	CcSEcCtD
Vismodegib—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000121	0.00224	CcSEcCtD
Vismodegib—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000121	0.00223	CcSEcCtD
Vismodegib—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00012	0.00223	CcSEcCtD
Vismodegib—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.00012	0.00223	CcSEcCtD
Vismodegib—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00012	0.00223	CcSEcCtD
Vismodegib—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.00222	CcSEcCtD
Vismodegib—Constipation—Vincristine—peripheral nervous system neoplasm	0.00012	0.00222	CcSEcCtD
Vismodegib—Pain—Vincristine—peripheral nervous system neoplasm	0.00012	0.00222	CcSEcCtD
Vismodegib—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.00222	CcSEcCtD
Vismodegib—Rash—Melphalan—peripheral nervous system neoplasm	0.000119	0.00221	CcSEcCtD
Vismodegib—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000119	0.00221	CcSEcCtD
Vismodegib—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000119	0.0022	CcSEcCtD
Vismodegib—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000118	0.00219	CcSEcCtD
Vismodegib—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000118	0.00218	CcSEcCtD
Vismodegib—SMO—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000118	0.00459	CbGpPWpGaD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000118	0.00217	CcSEcCtD
Vismodegib—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000117	0.00216	CcSEcCtD
Vismodegib—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000117	0.00216	CcSEcCtD
Vismodegib—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000115	0.00213	CcSEcCtD
Vismodegib—Nausea—Topotecan—peripheral nervous system neoplasm	0.000115	0.00212	CcSEcCtD
Vismodegib—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000115	0.00212	CcSEcCtD
Vismodegib—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000114	0.00211	CcSEcCtD
Vismodegib—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000114	0.00211	CcSEcCtD
Vismodegib—ABCG2—cerebellum—peripheral nervous system neoplasm	0.000113	0.00711	CbGeAlD
Vismodegib—SHH—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000113	0.00442	CbGpPWpGaD
Vismodegib—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000113	0.00209	CcSEcCtD
Vismodegib—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000112	0.00208	CcSEcCtD
Vismodegib—Nausea—Melphalan—peripheral nervous system neoplasm	0.000112	0.00208	CcSEcCtD
Vismodegib—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.00206	CcSEcCtD
Vismodegib—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000111	0.00205	CcSEcCtD
Vismodegib—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00011	0.00204	CcSEcCtD
Vismodegib—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.00202	CcSEcCtD
Vismodegib—SHH—Disease—GNS—peripheral nervous system neoplasm	0.000109	0.00426	CbGpPWpGaD
Vismodegib—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.00202	CcSEcCtD
Vismodegib—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.002	CcSEcCtD
Vismodegib—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.00199	CcSEcCtD
Vismodegib—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000108	0.00199	CcSEcCtD
Vismodegib—SMO—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000107	0.00419	CbGpPWpGaD
Vismodegib—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000107	0.00198	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000107	0.00198	CcSEcCtD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000106	0.00414	CbGpPWpGaD
Vismodegib—Pain—Cisplatin—peripheral nervous system neoplasm	0.000106	0.00196	CcSEcCtD
Vismodegib—ABCG2—HIF-1-alpha transcription factor network—ABCB1—peripheral nervous system neoplasm	0.000106	0.00412	CbGpPWpGaD
Vismodegib—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000104	0.00407	CbGpPWpGaD
Vismodegib—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000104	0.00193	CcSEcCtD
Vismodegib—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000104	0.00406	CbGpPWpGaD
Vismodegib—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000103	0.0019	CcSEcCtD
Vismodegib—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000101	0.00187	CcSEcCtD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000101	0.00393	CbGpPWpGaD
Vismodegib—Asthenia—Vincristine—peripheral nervous system neoplasm	0.0001	0.00186	CcSEcCtD
Vismodegib—Vomiting—Dactinomycin—peripheral nervous system neoplasm	9.97e-05	0.00184	CcSEcCtD
Vismodegib—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	9.94e-05	0.00184	CcSEcCtD
Vismodegib—SHH—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	9.9e-05	0.00387	CbGpPWpGaD
Vismodegib—Rash—Dactinomycin—peripheral nervous system neoplasm	9.88e-05	0.00183	CcSEcCtD
Vismodegib—Decreased appetite—Etoposide—peripheral nervous system neoplasm	9.86e-05	0.00182	CcSEcCtD
Vismodegib—SHH—Signaling by GPCR—VIP—peripheral nervous system neoplasm	9.8e-05	0.00383	CbGpPWpGaD
Vismodegib—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	9.79e-05	0.00181	CcSEcCtD
Vismodegib—Fatigue—Etoposide—peripheral nervous system neoplasm	9.78e-05	0.00181	CcSEcCtD
Vismodegib—SHH—Ectoderm Differentiation—MYC—peripheral nervous system neoplasm	9.75e-05	0.00381	CbGpPWpGaD
Vismodegib—Pain—Etoposide—peripheral nervous system neoplasm	9.7e-05	0.00179	CcSEcCtD
Vismodegib—Constipation—Etoposide—peripheral nervous system neoplasm	9.7e-05	0.00179	CcSEcCtD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	9.62e-05	0.00376	CbGpPWpGaD
Vismodegib—Diarrhoea—Vincristine—peripheral nervous system neoplasm	9.58e-05	0.00177	CcSEcCtD
Vismodegib—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	9.51e-05	0.00372	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	9.39e-05	0.00367	CbGpPWpGaD
Vismodegib—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	9.36e-05	0.00173	CcSEcCtD
Vismodegib—Nausea—Dactinomycin—peripheral nervous system neoplasm	9.31e-05	0.00172	CcSEcCtD
Vismodegib—SMO—Signaling by GPCR—VIP—peripheral nervous system neoplasm	9.29e-05	0.00363	CbGpPWpGaD
Vismodegib—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	9.28e-05	0.00172	CcSEcCtD
Vismodegib—Vomiting—Alitretinoin—peripheral nervous system neoplasm	9.24e-05	0.00171	CcSEcCtD
Vismodegib—Rash—Alitretinoin—peripheral nervous system neoplasm	9.16e-05	0.0017	CcSEcCtD
Vismodegib—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	9.15e-05	0.00169	CcSEcCtD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	9.12e-05	0.00356	CbGpPWpGaD
Vismodegib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	9.06e-05	0.00354	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	9.05e-05	0.00353	CbGpPWpGaD
Vismodegib—Abdominal pain—Etoposide—peripheral nervous system neoplasm	8.97e-05	0.00166	CcSEcCtD
Vismodegib—Vomiting—Vincristine—peripheral nervous system neoplasm	8.9e-05	0.00165	CcSEcCtD
Vismodegib—Asthenia—Cisplatin—peripheral nervous system neoplasm	8.88e-05	0.00164	CcSEcCtD
Vismodegib—Rash—Vincristine—peripheral nervous system neoplasm	8.83e-05	0.00163	CcSEcCtD
Vismodegib—Dermatitis—Vincristine—peripheral nervous system neoplasm	8.82e-05	0.00163	CcSEcCtD
Vismodegib—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	8.8e-05	0.00163	CcSEcCtD
Vismodegib—Nausea—Alitretinoin—peripheral nervous system neoplasm	8.63e-05	0.0016	CcSEcCtD
Vismodegib—SMO—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	8.58e-05	0.00335	CbGpPWpGaD
Vismodegib—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	8.47e-05	0.00157	CcSEcCtD
Vismodegib—Nausea—Vincristine—peripheral nervous system neoplasm	8.32e-05	0.00154	CcSEcCtD
Vismodegib—Asthenia—Etoposide—peripheral nervous system neoplasm	8.14e-05	0.00151	CcSEcCtD
Vismodegib—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	8.14e-05	0.00151	CcSEcCtD
Vismodegib—Pruritus—Etoposide—peripheral nervous system neoplasm	8.03e-05	0.00149	CcSEcCtD
Vismodegib—Alopecia—Epirubicin—peripheral nervous system neoplasm	7.91e-05	0.00146	CcSEcCtD
Vismodegib—Vomiting—Cisplatin—peripheral nervous system neoplasm	7.87e-05	0.00146	CcSEcCtD
Vismodegib—Rash—Cisplatin—peripheral nervous system neoplasm	7.81e-05	0.00144	CcSEcCtD
Vismodegib—Dermatitis—Cisplatin—peripheral nervous system neoplasm	7.8e-05	0.00144	CcSEcCtD
Vismodegib—Malnutrition—Epirubicin—peripheral nervous system neoplasm	7.79e-05	0.00144	CcSEcCtD
Vismodegib—Diarrhoea—Etoposide—peripheral nervous system neoplasm	7.76e-05	0.00144	CcSEcCtD
Vismodegib—SHH—Signaling Pathways—NTS—peripheral nervous system neoplasm	7.64e-05	0.00299	CbGpPWpGaD
Vismodegib—SHH—Disease—PPP3R1—peripheral nervous system neoplasm	7.63e-05	0.00298	CbGpPWpGaD
Vismodegib—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	7.63e-05	0.00141	CcSEcCtD
Vismodegib—Back pain—Epirubicin—peripheral nervous system neoplasm	7.54e-05	0.00139	CcSEcCtD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	7.51e-05	0.00294	CbGpPWpGaD
Vismodegib—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	7.49e-05	0.00139	CcSEcCtD
Vismodegib—Nausea—Cisplatin—peripheral nervous system neoplasm	7.35e-05	0.00136	CcSEcCtD
Vismodegib—SHH—Signaling Pathways—CD55—peripheral nervous system neoplasm	7.33e-05	0.00286	CbGpPWpGaD
Vismodegib—Alopecia—Doxorubicin—peripheral nervous system neoplasm	7.32e-05	0.00135	CcSEcCtD
Vismodegib—SMO—Signaling Pathways—NTS—peripheral nervous system neoplasm	7.24e-05	0.00283	CbGpPWpGaD
Vismodegib—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	7.22e-05	0.00282	CbGpPWpGaD
Vismodegib—Vomiting—Etoposide—peripheral nervous system neoplasm	7.21e-05	0.00133	CcSEcCtD
Vismodegib—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	7.21e-05	0.00133	CcSEcCtD
Vismodegib—Rash—Etoposide—peripheral nervous system neoplasm	7.15e-05	0.00132	CcSEcCtD
Vismodegib—Dermatitis—Etoposide—peripheral nervous system neoplasm	7.15e-05	0.00132	CcSEcCtD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	7.12e-05	0.00278	CbGpPWpGaD
Vismodegib—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	7.06e-05	0.00131	CcSEcCtD
Vismodegib—Back pain—Doxorubicin—peripheral nervous system neoplasm	6.97e-05	0.00129	CcSEcCtD
Vismodegib—SMO—Signaling Pathways—CD55—peripheral nervous system neoplasm	6.94e-05	0.00271	CbGpPWpGaD
Vismodegib—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	6.93e-05	0.00128	CcSEcCtD
Vismodegib—Nausea—Etoposide—peripheral nervous system neoplasm	6.74e-05	0.00125	CcSEcCtD
Vismodegib—Arthralgia—Epirubicin—peripheral nervous system neoplasm	6.63e-05	0.00123	CcSEcCtD
Vismodegib—Myalgia—Epirubicin—peripheral nervous system neoplasm	6.63e-05	0.00123	CcSEcCtD
Vismodegib—SHH—Disease—ENO2—peripheral nervous system neoplasm	6.61e-05	0.00258	CbGpPWpGaD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	6.59e-05	0.00122	CcSEcCtD
Vismodegib—ALB—Platelet degranulation—KNG1—peripheral nervous system neoplasm	6.5e-05	0.00254	CbGpPWpGaD
Vismodegib—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	6.27e-05	0.00245	CbGpPWpGaD
Vismodegib—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	6.24e-05	0.00115	CcSEcCtD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	6.2e-05	0.00242	CbGpPWpGaD
Vismodegib—Skin disorder—Epirubicin—peripheral nervous system neoplasm	6.18e-05	0.00114	CcSEcCtD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	6.17e-05	0.00241	CbGpPWpGaD
Vismodegib—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	6.14e-05	0.00114	CcSEcCtD
Vismodegib—Myalgia—Doxorubicin—peripheral nervous system neoplasm	6.14e-05	0.00114	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	6.1e-05	0.00113	CcSEcCtD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	6.06e-05	0.00237	CbGpPWpGaD
Vismodegib—ABCG2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	5.98e-05	0.00234	CbGpPWpGaD
Vismodegib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	5.97e-05	0.00233	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	5.85e-05	0.00229	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.81e-05	0.00227	CbGpPWpGaD
Vismodegib—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	5.79e-05	0.00107	CcSEcCtD
Vismodegib—SHH—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.79e-05	0.00226	CbGpPWpGaD
Vismodegib—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	5.77e-05	0.00107	CcSEcCtD
Vismodegib—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	5.71e-05	0.00106	CcSEcCtD
Vismodegib—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	5.6e-05	0.00104	CcSEcCtD
Vismodegib—ABCB1—cerebellum—peripheral nervous system neoplasm	5.59e-05	0.00351	CbGeAlD
Vismodegib—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	5.53e-05	0.00102	CcSEcCtD
Vismodegib—SMO—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.51e-05	0.00215	CbGpPWpGaD
Vismodegib—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	5.49e-05	0.00102	CcSEcCtD
Vismodegib—SMO—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.49e-05	0.00214	CbGpPWpGaD
Vismodegib—Fatigue—Epirubicin—peripheral nervous system neoplasm	5.48e-05	0.00101	CcSEcCtD
Vismodegib—Pain—Epirubicin—peripheral nervous system neoplasm	5.44e-05	0.00101	CcSEcCtD
Vismodegib—Constipation—Epirubicin—peripheral nervous system neoplasm	5.44e-05	0.00101	CcSEcCtD
Vismodegib—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	5.42e-05	0.00212	CbGpPWpGaD
Vismodegib—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	5.36e-05	0.000992	CcSEcCtD
Vismodegib—SHH—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.34e-05	0.00209	CbGpPWpGaD
Vismodegib—SHH—Disease—SLC2A1—peripheral nervous system neoplasm	5.33e-05	0.00208	CbGpPWpGaD
Vismodegib—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	5.31e-05	0.00207	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	5.21e-05	0.00204	CbGpPWpGaD
Vismodegib—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	5.2e-05	0.000962	CcSEcCtD
Vismodegib—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	5.18e-05	0.000958	CcSEcCtD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	5.16e-05	0.00202	CbGpPWpGaD
Vismodegib—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	5.11e-05	0.000946	CcSEcCtD
Vismodegib—SHH—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.08e-05	0.00199	CbGpPWpGaD
Vismodegib—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.08e-05	0.00094	CcSEcCtD
Vismodegib—Fatigue—Doxorubicin—peripheral nervous system neoplasm	5.07e-05	0.000939	CcSEcCtD
Vismodegib—SMO—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.07e-05	0.00198	CbGpPWpGaD
Vismodegib—Pain—Doxorubicin—peripheral nervous system neoplasm	5.03e-05	0.000931	CcSEcCtD
Vismodegib—Constipation—Doxorubicin—peripheral nervous system neoplasm	5.03e-05	0.000931	CcSEcCtD
Vismodegib—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	5.03e-05	0.00093	CcSEcCtD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	4.94e-05	0.00193	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.82e-05	0.00188	CbGpPWpGaD
Vismodegib—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.81e-05	0.00089	CcSEcCtD
Vismodegib—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.65e-05	0.000861	CcSEcCtD
Vismodegib—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.000844	CcSEcCtD
Vismodegib—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.5e-05	0.000832	CcSEcCtD
Vismodegib—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.45e-05	0.00174	CbGpPWpGaD
Vismodegib—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.35e-05	0.000805	CcSEcCtD
Vismodegib—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.29e-05	0.00167	CbGpPWpGaD
Vismodegib—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000781	CcSEcCtD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4.19e-05	0.00164	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4.17e-05	0.00163	CbGpPWpGaD
Vismodegib—Pruritus—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	0.00077	CcSEcCtD
Vismodegib—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.04e-05	0.000748	CcSEcCtD
Vismodegib—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.03e-05	0.000745	CcSEcCtD
Vismodegib—SHH—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.01e-05	0.00157	CbGpPWpGaD
Vismodegib—Rash—Epirubicin—peripheral nervous system neoplasm	4.01e-05	0.000742	CcSEcCtD
Vismodegib—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4.01e-05	0.000741	CcSEcCtD
Vismodegib—SMO—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.8e-05	0.00149	CbGpPWpGaD
Vismodegib—Nausea—Epirubicin—peripheral nervous system neoplasm	3.78e-05	0.000699	CcSEcCtD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.74e-05	0.00146	CbGpPWpGaD
Vismodegib—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.74e-05	0.000692	CcSEcCtD
Vismodegib—Rash—Doxorubicin—peripheral nervous system neoplasm	3.71e-05	0.000686	CcSEcCtD
Vismodegib—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.71e-05	0.000686	CcSEcCtD
Vismodegib—SHH—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.53e-05	0.00138	CbGpPWpGaD
Vismodegib—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.49e-05	0.000647	CcSEcCtD
Vismodegib—SHH—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.43e-05	0.00134	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.41e-05	0.00133	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.35e-05	0.00131	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.27e-05	0.00128	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.25e-05	0.00127	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.1e-05	0.00121	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.01e-05	0.00118	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3e-05	0.00117	CbGpPWpGaD
Vismodegib—SHH—Disease—PTPN11—peripheral nervous system neoplasm	2.98e-05	0.00116	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	2.97e-05	0.00116	CbGpPWpGaD
Vismodegib—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.9e-05	0.00113	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	2.89e-05	0.00113	CbGpPWpGaD
Vismodegib—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	2.87e-05	0.00112	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.85e-05	0.00111	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.76e-05	0.00108	CbGpPWpGaD
Vismodegib—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	2.75e-05	0.00108	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.75e-05	0.00107	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	2.71e-05	0.00106	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.64e-05	0.00103	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	2.51e-05	0.000981	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	2.48e-05	0.000969	CbGpPWpGaD
Vismodegib—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	2.48e-05	0.000968	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.47e-05	0.000964	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.41e-05	0.000941	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	2.4e-05	0.000939	CbGpPWpGaD
Vismodegib—SHH—Disease—ERBB2—peripheral nervous system neoplasm	2.35e-05	0.00092	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.32e-05	0.000905	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.27e-05	0.000886	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.25e-05	0.000879	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	2.17e-05	0.00085	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.12e-05	0.00083	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	2.12e-05	0.000829	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.09e-05	0.000815	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	2.08e-05	0.000815	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.01e-05	0.000787	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	2.01e-05	0.000784	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.98e-05	0.000773	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.87e-05	0.000729	CbGpPWpGaD
Vismodegib—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.86e-05	0.000725	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.82e-05	0.000713	CbGpPWpGaD
Vismodegib—SHH—Disease—NRAS—peripheral nervous system neoplasm	1.79e-05	0.0007	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.79e-05	0.000699	CbGpPWpGaD
Vismodegib—SHH—Disease—MYC—peripheral nervous system neoplasm	1.67e-05	0.000652	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.67e-05	0.000651	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.65e-05	0.000644	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.63e-05	0.000635	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	1.6e-05	0.000627	CbGpPWpGaD
Vismodegib—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.57e-05	0.000613	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.56e-05	0.000611	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.55e-05	0.000607	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.55e-05	0.000606	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.54e-05	0.000603	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.52e-05	0.000594	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.5e-05	0.000585	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	1.49e-05	0.000581	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.48e-05	0.00058	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.47e-05	0.000575	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.42e-05	0.000554	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.4e-05	0.000547	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.38e-05	0.000541	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.37e-05	0.000536	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.36e-05	0.000533	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	1.35e-05	0.000527	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GNS—peripheral nervous system neoplasm	1.34e-05	0.000524	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	1.32e-05	0.000515	CbGpPWpGaD
Vismodegib—SHH—Disease—HRAS—peripheral nervous system neoplasm	1.31e-05	0.000512	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	1.3e-05	0.000508	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.3e-05	0.000508	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.29e-05	0.000506	CbGpPWpGaD
Vismodegib—ALB—Metabolism—NME1—peripheral nervous system neoplasm	1.29e-05	0.000503	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.26e-05	0.000493	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.25e-05	0.00049	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.25e-05	0.000487	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	1.24e-05	0.000484	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.24e-05	0.000484	CbGpPWpGaD
Vismodegib—ALB—Metabolism—COX2—peripheral nervous system neoplasm	1.24e-05	0.000484	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.23e-05	0.000479	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.2e-05	0.000471	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.19e-05	0.000465	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.18e-05	0.000459	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.17e-05	0.000457	CbGpPWpGaD
Vismodegib—SHH—Disease—AKT1—peripheral nervous system neoplasm	1.16e-05	0.000452	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.15e-05	0.000451	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.13e-05	0.00044	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.13e-05	0.00044	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	1.11e-05	0.000435	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.11e-05	0.000434	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.11e-05	0.000433	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.1e-05	0.000432	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.1e-05	0.000429	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.09e-05	0.000424	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.06e-05	0.000415	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.05e-05	0.000411	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	1.05e-05	0.000409	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.01e-05	0.000396	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1e-05	0.000391	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.86e-06	0.000385	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	9.67e-06	0.000378	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.6e-06	0.000375	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.18e-06	0.000359	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.1e-06	0.000355	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	9.04e-06	0.000353	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.7e-06	0.00034	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	8.54e-06	0.000334	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	8.38e-06	0.000328	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	8.18e-06	0.000319	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	8.13e-06	0.000318	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.1e-06	0.000317	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	7.94e-06	0.00031	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.68e-06	0.0003	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	7.3e-06	0.000285	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	7.24e-06	0.000283	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	7.12e-06	0.000278	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	6.95e-06	0.000271	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	6.91e-06	0.00027	CbGpPWpGaD
Vismodegib—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	6.87e-06	0.000268	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	6.81e-06	0.000266	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	6.71e-06	0.000262	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	6.69e-06	0.000261	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	6.65e-06	0.00026	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.59e-06	0.000258	CbGpPWpGaD
Vismodegib—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.55e-06	0.000256	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	6.5e-06	0.000254	CbGpPWpGaD
Vismodegib—ALB—Metabolism—TH—peripheral nervous system neoplasm	6.46e-06	0.000252	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	6.17e-06	0.000241	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	6.02e-06	0.000235	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.88e-06	0.00023	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	5.8e-06	0.000227	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.74e-06	0.000224	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	5.66e-06	0.000221	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	5.62e-06	0.00022	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	5.43e-06	0.000212	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.36e-06	0.00021	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	5.3e-06	0.000207	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	5.29e-06	0.000207	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	5.27e-06	0.000206	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	5.2e-06	0.000203	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	5.17e-06	0.000202	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	4.73e-06	0.000185	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	4.64e-06	0.000181	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	4.62e-06	0.000181	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	4.39e-06	0.000171	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	4.32e-06	0.000169	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	4.24e-06	0.000165	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	4.16e-06	0.000162	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	3.98e-06	0.000155	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	3.71e-06	0.000145	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.54e-06	0.000138	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	3.51e-06	0.000137	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	3.49e-06	0.000136	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	2.85e-06	0.000111	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.79e-06	0.000109	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	2.31e-06	9.01e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	1.43e-06	5.59e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	1.42e-06	5.56e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.28e-06	4.99e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.25e-06	4.87e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.16e-06	4.55e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	7.68e-07	3e-05	CbGpPWpGaD
